NCT00813020View on ClinicalTrials.gov

A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

semaglutide

Comparison of different formulations of the drug, semaglutide: Formulation 1 administered in equimolar doses

DRUG

semaglutide

Comparison of different formulations of the drug, semaglutide: Formulation 2 administered in equimolar doses

DRUG

semaglutide

Comparison of different formulations of the drug, semaglutide: Formulation 3 administered in equimolar doses

Trial Locations (1)

14050

Berlin

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY